Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-18-002304
Filing Date
2018-08-07
Accepted
2018-08-07 07:06:24
Documents
30
Period of Report
2018-08-07

Document Format Files

Seq Description Document Type Size
1 6-K zk1821978.htm 6-K 14339
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 289641
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 678492
10 image00003.jpg GRAPHIC 3263
  Complete submission text file 0001178913-18-002304.txt   2274262

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mdwd-20180630.xml EX-101.INS 291145
5 XBRL TAXONOMY EXTENSION SCHEMA mdwd-20180630.xsd EX-101.SCH 16948
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdwd-20180630_cal.xml EX-101.CAL 43106
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdwd-20180630_def.xml EX-101.DEF 36908
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdwd-20180630_lab.xml EX-101.LAB 155747
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdwd-20180630_pre.xml EX-101.PRE 107790
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36349 | Film No.: 18996255
SIC: 2833 Medicinal Chemicals & Botanical Products